Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
wuAy5SZY50nX2YeT
